About
Viral Vector Therapeutics, Gene Therapy
Areas of Focus
Categories
Biologics & BiopharmaceuticalVirus TechnologyGene Therapy, RNA & Peptide Therapy
Clinical Trials (23)
View allTotal Trials
23
As Lead Sponsor
18
As Collaborator
5
Total Enrollment
1,695
By Phase
PHASE1: 6PHASE1/PHASE2: 9PHASE2: 5NA: 1PHASE2/PHASE3: 2
By Status
COMPLETED: 12TERMINATED: 6ACTIVE_NOT_RECRUITING: 2UNKNOWN: 2RECRUITING: 1
Clinical Trials Pipeline23 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT05788926Lead Sponsor
A Clinical Trial of TG6050 in Patients With Metastatic Non-Small Cell Lung Cancer (Delivir)
PHASE1Terminated
22 participants
Started: Apr 5, 2023 · Completed: Jun 23, 2025
NCT04725331Lead Sponsor
A Clinical Trial Assessing BT-001 Alone and in Combination With Pembrolizumab in Metastatic or Advanced Solid Tumors
PHASE1/PHASE2Recruiting
48 participants
Started: Feb 25, 2021 · Completed: Apr 30, 2025
NCT04194034Lead Sponsor
Study of Intrahepatic Arterial Infusion of TG6002 in Combination With 5-FC in Patients With Metastatic Colorectal Cancer
PHASE1/PHASE2Terminated
15 participants
Started: Jan 17, 2020 · Completed: Feb 23, 2023
NCT04183166Lead Sponsor
A Clinical Trial Evaluating TG4050 in Head and Neck Cancer
PHASE1/PHASE2Active, not recruiting
80 participants
Started: Dec 12, 2019 · Completed: Dec 30, 2028
NCT03839524Lead Sponsor
A Trial Evaluating TG4050 in Ovarian Carcinoma.
PHASE1Completed
64 participants
Started: Dec 9, 2019 · Completed: Oct 8, 2024
Locations (1)
Headquarters
Illkirch-Graffenstaden, France
Map
Loading map...